Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2008 Sep;7(9):2876–2883. doi: 10.1158/1535-7163.MCT-08-0431

Table 2.

Frequency of CCND1 amplification in melanoma cell lines and melanoma tumor samples

Total number of samples 47 Melanoma cell lines (%) 67 Melanoma tumor samples (%)
Total CGH CCND1 amplifications 12/47 (25) 11/67 (17)
CCND1 amplifications, BRAF group 9/36 (25) 7/29 (24)
CCND1 amplifications, NRAS group 1/8 (12.5) 2/18 (11)
CCND1 amplifications, BRAF/NRAS wild-type 2/3 (67) 2/20 (10)